• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON ENDO-SURGERY, LLC. ENSEAL GENERIC PRODUCT CODE; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON ENDO-SURGERY, LLC. ENSEAL GENERIC PRODUCT CODE; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES Back to Search Results
Catalog Number NSEALXXX
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Hemorrhage/Bleeding (1888); Pain (1994)
Event Date 09/17/2021
Event Type  Injury  
Event Description
Title: laparoscopic sleeve gastrectomy versus laparoscopic greater curvature plication: a long-term follow-up study on the complications, body mass index changes, endoscopic findings and causes of revision.Authors: mohamed ibrahim, mohamed hany, ahmed zidan, anwar ashraf abouelnasr, ghada ahmed abu-sheasha.Citation: obesity surgery (2021) 31:5275¿5285, https://doi.Org/10.1007/s11695-021-05683-5.The aim of this study was to compare the long-term outcomes and clinical relevance of laparoscopic sleeve gastrectomy (lsg) and laparoscopic greater curvature plication (lgcp) in a matched controlled single bariatric centre study.Between january 2015 and february 2016, 163 patients who underwent either laparoscopic sleeve gastrectomy or laparoscopic greater curvature plication for morbid obesity were included in the study.A total of 79 patients (60 females, 19 males, mean age 35.7 ± 8.3 years, mean bmi 44.3 ± 2.3 kg/m2) underwent laparoscopic greater curvature plication while 84 patients (67 females, 17 males, mean age 35.0 ± 9.1 years, mean bmi 43.1 ± 2.8 kg/m2) underwent laparoscopic sleeve gastrectomy.For the laparoscopic greater curvature plication procedure, the enseal (ethicon endo-surgery) was used to divide the gastrocolic omentum 3¿5 cm proximal to the pylorus which continued up to the angle of his.The fundus was completely dissected then the gastric plication was performed using the 2/0 ethibond suture (ethicon).For the laparoscopic sleeve gastrectomy procedure, all procedures were performed using a technique similar to that used for the laparoscopic greater curvature plication procedure.An echelon flex endopath 60-mm direct stapler (ethicon endo-surgery) was used for gastric division, beginning at 3¿5 cm before the pylorus and up to the angle of his.The entire staple line was invaginated using continuous seromuscular sutures with 3/0 pds sutures (ethicon).The reported complications included gastric leakage (n=1), bleeding of the short gastric vessels (n=1), nausea (n=11), vomiting (n=11), epigastric pain (n=24), gastroesophageal reflux (n=?), bile reflux (n=?), and weight gain (n=?).In conclusion, laparoscopic greater curvature plication has a higher rate of complications, a much less durable effect on weight loss, a higher rate of revision surgery and a higher cost burden to the health care system than laparoscopic sleeve gastrectomy.
 
Manufacturer Narrative
(b)(4).Event date: publication year of 2021.Batch # unk.This report is related to a journal article; therefore, no product will be returned for analysis and the manufacturing records cannot be reviewed as the lot/batch number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Does the author/surgeon believe that the ethicon device caused or contributed to the patient complications mentioned in the article? if yes, please explain.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENSEAL GENERIC PRODUCT CODE
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES
Manufacturer (Section D)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
*  00969
Manufacturer (Section G)
ETHICON ENDO-SURGERY, LLC.
475 calle c
guaynabo 00969
*   00969
Manufacturer Contact
orla o'mahony
475 calle c
guaynabo 
*  
329348013
MDR Report Key15470757
MDR Text Key300443731
Report Number3005075853-2022-06337
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeEG
PMA/PMN Number
K072177
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 09/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberNSEALXXX
Was Device Available for Evaluation? No
Date Manufacturer Received08/29/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-